A Retrospective, Observational Analysis of the Prevalence of Primary Immunodeficiencies in Younger Patients with Lymphoma Read more
An Open-Label Study To Assess The Anti-Tumor Activity And Safety Of Regn1979, An Anti-Cd20 X Anti-Cd3 Bispecific Antibody, In Patients With Relapsed Or Refractory Follicular Lymphoma Read more
A multicenter Retrospective Study of Rapid Ramp-up of Bispecific Antibodies for Relapsed or Refractory Large B-cell Lymphoma Read more
Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Loncastuximab: A Real World Multicenter Analysis Read more
A Phase 2 Study to Evaluate the Efficacy and Safety of MK-1026 in Participants with Hematologic Malignancies Read more
A Phase 3, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib Versus Ibrutinib as 1L+ Therapy in Participants with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011) Read more
A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of ITK Inhibitor Soquelitinib Versus Physicians Choice Standard of Care Treatment (Selected Single Agent) in Participants with Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma Read more
